最終更新日：2025/11/27
The prescriptibility of the new medication was debated at the panel, as regulators weighed potential benefits against risks.
正解を見る
The prescriptibility of the new medication was debated at the panel, as regulators weighed potential benefits against risks.
音声機能が動作しない場合はこちらをご確認ください
編集履歴（0）
